Mimbi vs MolecularMatch: Revenue, Funding & Team Size Compared
Mimbi generates $880K in revenue; MolecularMatch generates $880K. Mimbi and MolecularMatch are close to the same size by revenue. The table below compares Mimbi and MolecularMatch on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  MimbiThis company |  MolecularMatch |
|---|---|---|
| Revenue | $880K | $880K |
| Team size | 8 | 8 |
| Founded | 2023 | 2014 |
| HQ | Paris, France | Houston, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Mimbi at a glance
Mimbi generates $880K in revenue with 8 employees, headquartered in Paris, France.
- Revenue
- $880K
- Team size
- 8
- Founded
- 2023
mimbi helps brands and agencies to measure and optimize the impact of their investments in retail media. Through a SAAS platform, mimbi offers the following capabilities to commerce media buyers: - unified analytics: connect & organize all…
MolecularMatch at a glance
MolecularMatch generates $880K in revenue with 8 employees, headquartered in Houston, United States.
- Revenue
- $880K
- Team size
- 8
- Founded
- 2014
MolecularMatch, Inc. is a Houston, Texas-based clinical informatics SaaS company founded in 2014 out of MD Anderson Cancer Center. The company was founded on the vision of using tumor molecular profiling, and outcomes from…
Other Mimbi alternatives
Mimbi competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Mimbi vs MolecularMatch: frequently asked questions
Is Mimbi or MolecularMatch bigger?
Mimbi is the bigger company by revenue, at $880K against $880K for MolecularMatch.
How much revenue does Mimbi make?
Mimbi generates $880K in annual revenue with a team of 8.
How much revenue does MolecularMatch make?
MolecularMatch generates $880K in annual revenue with a team of 8.